Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pliant Therapeutics (PLRX)
NASDAQ:PLRX
Pliant Therapeutics (PLRX) Stock Price & Analysis
243 Followers
PLRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.47 - $36.64
Previous Close$17.06
Volume170.89K
Average Volume (3M)649.96K
Market Cap
$941.20M
Enterprise Value$419.72M
Total Cash (Recent Filing)$555.16M
Total Debt (Recent Filing)$14.54M
Price to Earnings (P/E)-6.2
Beta0.82
Next Earnings
Nov 07, 2023EPS Estimate
-$0.77Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.74
Shares Outstanding59,834,098
10 Day Avg. Volume1,075,797
30 Day Avg. Volume649,963
Standard Deviation0.29
R-Squared0.05
Alpha0.00250
Financial Highlights & Ratios
Price to Book (P/B)1.95
Price to Sales (P/S)4116.01
Price to Cash Flow (P/CF)-10.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue83.49
Enterprise Value/Gross Profit43.34
Enterprise Value/Ebitda-2.58
Forecast
1Y Price Target
$48.82Price Target Upside191.99% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Pliant Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PLRX FAQ
What was Pliant Therapeutics’s price range in the past 12 months?
Pliant Therapeutics lowest stock price was $14.47 and its highest was $36.64 in the past 12 months.
What is Pliant Therapeutics’s market cap?
Currently, no data Available
When is Pliant Therapeutics’s upcoming earnings report date?
Pliant Therapeutics’s upcoming earnings report date is Nov 07, 2023 which is in 34 days.
How were Pliant Therapeutics’s earnings last quarter?
Pliant Therapeutics released its earnings results on Aug 09, 2023. The company reported -$0.7 earnings per share for the quarter, beating the consensus estimate of -$0.713 by $0.013.
Is Pliant Therapeutics overvalued?
According to Wall Street analysts Pliant Therapeutics’s price is currently Undervalued.
Does Pliant Therapeutics pay dividends?
Pliant Therapeutics does not currently pay dividends.
What is Pliant Therapeutics’s EPS estimate?
Pliant Therapeutics’s EPS estimate is -$0.77.
How many shares outstanding does Pliant Therapeutics have?
Pliant Therapeutics has 59,834,100 shares outstanding.
What happened to Pliant Therapeutics’s price movement after its last earnings report?
Pliant Therapeutics reported an EPS of -$0.7 in its last earnings report, beating expectations of -$0.713. Following the earnings report the stock price went up 3.3%.
Which hedge fund is a major shareholder of Pliant Therapeutics?
Among the largest hedge funds holding Pliant Therapeutics’s share is RA Capital Management. It holds Pliant Therapeutics’s shares valued at 32M.
---
Pliant Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$48.82 (191.99% Upside)
$48.82 (191.99% Upside)
Blogger Sentiment
Bullish
PLRX Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 339.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.0%
Last 30 Days ▼ 5.9%
Last 30 Days ▼ 5.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.83%
12-Months-Change
Fundamentals
Return on Equity
-42.42%
Trailing 12-Months
Asset Growth
211.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Pliant Therapeutics
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
---
Top 5 ETFs holding PLRX
Vanguard Total Stock Market ETF
$26.12M
Vanguard Health Care ETF
$2.43M
Schwab U.S. Broad Market ETF
$499.35K
iShares Russell 3000 ETF
$250.41K
Vanguard Russell 3000 ETF
$59.70K
Up to five ETFs with an Outperform Smart Score that hold PLRX. The ETFs are listed according to market value of PLRX within the ETF
---